GSK-444563/014 (Rota-014)

Study Sponsor: GSK

Study Title

Study of safety, reactogenicity and immunogenicity of two doses of GSK Bio’s oral live attenuated human rotavirus vaccine co-administered with either oral polio vaccine (OPV) or inactivated polio vaccine (IPV) in healthy infants in South Africa

Medicine or Vaccine (generic name)

Rotavirus Vaccine

Sponsor Identification Number

444563/014 (Rota-014)

Trial Registry Identification Number(#'s)

NCT00346892

Medical Condition

Infections, Rotavirus

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=444563/014

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00346892

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

June 2015